NCT06246916 2026-02-19
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Regeneron Pharmaceuticals
Phase 3 Recruiting
Regeneron Pharmaceuticals
OncoNano Medicine, Inc.
Regeneron Pharmaceuticals
Vyriad, Inc.
OncoResponse, Inc.